Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
Ashford, J. WessonVolume:
94
Journal:
Neurology
DOI:
10.1212/wnl.0000000000009184
Date:
March, 2020
File:
PDF, 141 KB
2020